Advertisement
Universe Pharmaceuticals Inc.

Universe Pharmaceuticals Inc. (UPC) Stock Overview

Explore Universe Pharmaceuticals Inc.’s financial performance, market position, analyst ratings, and future outlook.

UPCNASDAQ
HealthcareDrug Manufacturers - Specialty & Generic
$3.24
$0.010(0.31%)
U.S. Market opens in 51h 10m
Advertisement

Universe Pharmaceuticals Inc. (UPC)

Meyka AI Score

Z

Key Financials

Market Cap1.8M
P/E Ratio-0.49
EPS (TTM)$-8.06
ROE-0.07%
Fundamental Analysis

AI Price Forecasts

1 Month$6.18
3 Months$24.96
1 Year Target$0.00

UPC Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Universe Pharmaceuticals Inc. (UPC) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of C+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 53.95, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $0.00.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -0.49 and a market capitalization of 1.8M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-0.31%
5-Day Change
6.23%
1-Month Change
24.61%
3-Month Change
33.33%
6-Month Change
-18.60%
Year-to-Date (YTD) Change
-14.96%
1-Year Change
-16.71%
3-Year Change
-99.90%
5-Year Change
-99.97%
All-Time (Max) Change
-99.98%

Contact Information

86 571 8755 5823
No. 265, Jingjiu Avenue, Ji'An, NaN, 343100

Company Facts

225 Employees
IPO DateMar 23, 2021
CountryCN
Actively Trading

Frequently Asked Questions